Insulet (PODD) Return on Equity [ROE] (2009 - 2026)
Insulet (PODD) reported Return on Equity [ROE] of 27.55% for Q2 2026, up 10.64 percentage points from 16.91% a year earlier and up 6.06 percentage points from the prior quarter.
Insulet (PODD) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Insulet posted Return on Equity [ROE] of 18.12%, down 24.90 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +16.12 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 43.03% in FY2024 (+8.89 pp), 34.14% in FY2023 (+33.25 pp), 0.89% in FY2022 (-2.01 pp) and 2.90% in FY2021 (+0.90 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2025.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of -5.37 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2024 (a gain of 32.30 percentage points); the low point was Q2 2025 (a drop of 27.29 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.50% (Q1 2026), 17.06% (Q4 2025) and 17.30% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 13.20% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 9.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 8.15% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 17.28% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 17.46% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | -4.01% |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 13.69% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 9.36% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 4.56% |
| 10 | Insulet | 10.27 Bn | 7.96 Bn | 632.10 Mn | 28.58% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 28.58% |
| Jun 30, 2026 | 27.55% |
| Mar 31, 2026 | 21.50% |
| Dec 31, 2025 | 17.06% |
| Sep 30, 2025 | 17.30% |
| Jun 30, 2025 | 16.91% |
| Mar 31, 2025 | 31.65% |
| Dec 31, 2024 | 35.91% |
| Sep 30, 2024 | 39.78% |
| Jun 30, 2024 | 44.20% |
| Mar 31, 2024 | 30.73% |
| Dec 31, 2023 | 30.80% |
| Sep 30, 2023 | 20.66% |
| Jun 30, 2023 | 11.90% |
| Mar 31, 2023 | 0.12% |
| Dec 31, 2022 | 1.02% |
| Sep 30, 2022 | 3.95% |
| Jun 30, 2022 | 7.96% |
| Mar 31, 2022 | 8.89% |
| Dec 31, 2021 | 3.19% |
Insulet Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PODD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PODD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PODD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();